Adalimumab
NDC 61314-325, adalimumab-adaz, injection, solution, from Sandoz Inc.
- Product NDC
- 61314-325
- Status
- Listed
- Labeler
- Sandoz Inc
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761071
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/61314-325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ADALIMUMAB80 mg/.8mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 61314-325-20 | 61314032520 | 2 SYRINGE in 1 CARTON (61314-325-20) / .8 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3468792f-63ef-4916-8ed1-8214f327d9dd
Use it
Look up 61314-325 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/61314-325 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 61314-325. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.